Dr. Ogunseinde noted, “Developed with SI-BONE in Longview, Texas, the posteromedial technique is designed to transform the treatment of SI joint dysfunction. Its simplicity enables physicians to treat patients using a minimally invasive approach, enhancing both accessibility and efficiency in the OR.”
About SI-BONE, Inc. SI-BONE (NASDAQ: SIBN) is a leading provider of technology for the surgical treatment of sacropelvic disorders. Since 2009, SI-BONE has been at the forefront of minimally invasive SI joint surgery, supporting over 3,900 physicians in performing more than 100,000 sacropelvic procedures worldwide. SI-BONE’s technologies are backed by robust clinical evidence, including two randomized controlled trials and over 135 peerreviewed studies. Building on its expertise in minimally invasive SI joint fusion, SI-BONE has expanded into adjacent areas such as adult deformity, spinopelvic fixation, and pelvic trauma. For more information, visit www.si-bone.com.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
